A Genomic Comparison of in vivo and in vitro Brain Microvascular Endothelial Cells
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The blood—brain barrier (BBB) is composed of uniquely differentiated brain microvascular endothelial cells (BMEC). Often, it is of interest to replicate these attributes in the form of an in vitro model, and such models are widely used in the research community. However, the BMEC used to create in vitro BBB models de-differentiate in culture and lose many specialized characteristics. These changes are poorly understood at a molecular level, and little is known regarding the consequences of removing BMEC from their local in vivo microenvironment. To address these issues, suppression subtractive hybridization (SSH) was used to identify 25 gene transcripts that were differentially expressed between in vivo and in vitro BMEC. Genes affected included those involved in angiogenesis, transport and neurogenesis, and real-time quantitative polymerase chain reaction (qPCR) verified transcripts were primarily and significantly downregulated. Since this quantitative gene panel represented those BMEC characteristics lost upon culture, we used it to assess how culture manipulation, specifically BMEC purification and barrier induction by hydrocortisone, influenced the quality of in vitro models. Puromycin purification of BMEC elicited minimal differences compared with untreated BMEC, as assessed by qPCR. In contrast, qPCR-based gene panel analysis after induction with hydrocortisone indicated a modest shift of 10 of the 23 genes toward a more ‘ in vivo-like’ gene expression profile, which correlated with improved barrier phenotype. Genomic analysis of BMEC de-differentiation in culture has thus yielded a functionally diverse set of genes useful for comparing the in vitro and in vivo BBB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pericytes, SMCs, and endothelial cells express thousands of transcripts encoding different transporters, receptors, active efflux pumps, ion channels, and regulatory molecules (28, 72, 86, 129, 242, 358, 359, 610, 675, 678), whose expression pattern varies by zonation along the arteriocapillary-venous axis and cell type (610).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [86]
In the citing paper
“The major BBB transporters, receptors, and channels in endothelial cells and pericytes have been validated by transcriptomic studies and/or protein analysis in the rodent brain (28, 72, 86, 129, 242, 358, 359, 675, 678) (FIGURE 3) .”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [86]
Citations
Cites
Endothelial Cells Stimulate Self-Renewal and Expand Neurogenesis of Neural Stem Cells
Shen, Q., Goderie, S. K., Jin, L., Karanth, N., Sun, Y., Abramova, N., Vincent, P., Pumiglia, K., & Temple, S. (2004) · Science · doi:10.1126/science.1095505 · Cited by 1,542 · cited 1×
“…combined with the confirmed expression of these genes by purified BMEC, these data suggest that BMEC may play an important role in the regulation of brain development and maturation, a theory that has been supported by various studies that indicate EC can regulate neurogenesis (Shen et al, 2004).”
ResultTransferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775 · cited 1×
“The transendothelial electrical resistance in cultured BMEC monocultures is often 100O cm2 or lower (Calabria et al, 2006; Rubin et al, 1991), well below the value of nearly 1,500O cm2 observed in the brain (Butt et al, 1990).”
BackgroundA cell culture model of the blood-brain barrier.
Rubin, L. L., Hall, D. E., Porter, S., Barbu, K., Cannon, C., Horner, H. C., Janatpour, M., Liaw, C. W., Manning, K., & Morales, J. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1725 · Cited by 765
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466 · cited 2×
“Peptides derived from a genetic mutant of ITM2B are found in perivascular amyloid deposits associated with familial British dementia (Vidal et al, 1999).”
BackgroundBetz, A. L., Firth, J. A., & Goldstein, G. W. (1980) · Brain Research · doi:10.1016/0006-8993(80)91004-5 · Cited by 400
Perrière, N., Demeuse, P., Garcia, E., Regina, A., Debray, M., Andreux, J. ‐., Couvreur, P., Scherrmann, J. ‐., Temsamani, J., Couraud, P. ‐., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.03020.x · Cited by 330
FGF-2-Responsive Neural Stem Cell Proliferation Requires CCg, a Novel Autocrine/Paracrine Cofactor
Taupin, P., Ray, J., Fischer, W. H., Suhr, S. T., Hakansson, K., Grubb, A., & Gage, F. H. (2000) · Neuron · doi:10.1016/s0896-6273(00)00119-7 · Cited by 313 · cited 1×
“Cystatin C has been reported to stimulate neural stem cell proliferation and neurogenesis in vivo (Taupin et al, 2000), in addition to promoting astrogenesis and suppressing oligodendrogenesis in vitro (Hasegawa et al, 2007), and has been linked to pathological processes such as cerebral amyloid…”
BackgroundKleinz, M. J., & Davenport, A. P. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2003.11.002 · Cited by 288 · cited 1×
“Apelin, AGTRL1 ligand APLN NM_031612 3 (Kleinz and Davenport, 2004) Angiogenesis/ vascular 6.”
Research works printed but not linked: 3
- Hiyama K, 2005, Int J Oncol, 27, 87
- Marroni M, 2003, Methods Mol Med, 89, 419
- Nakada M, 2003, Cancer Res, 63, 3364
Cited by
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Helms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P.-O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630991 · Cited by 843
“Influx transporters, such as Glut-1, are more sensitive to down-regulation by serum-free monolayer culture conditions than efflux pumps.(159) Garberg et al.”
BackgroundSelf-citationLooking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
Cardoso, F. L., Brites, D., & Brito, M. A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.003 · Cited by 569
Takeshita, Y., & Ransohoff, R. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01127.x · Cited by 325
Disruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
Pavličev, M., Wagner, G. P., Chavan, A. R., Owens, K., Maziarz, J., Dunn-Fletcher, C., Kallapur, S. G., Muglia, L., & Jones, H. (2017) · Genome Research · doi:10.1101/gr.207597.116 · Cited by 290
“A potential limitation to these data is that in vitro cell cultures could lack some gene expression that arises due to the in vivo context or by interaction with adjacent cell types (e.g., Calabria and Shusta 2008; Gellersen and Brosens 2014; LoVerso et al. 2015).”
Canfield, S. G., Stebbins, M. J., Morales, B. S., Asai, S. W., Vatine, G. D., Svendsen, C. N., Palecek, S. P., & Shusta, E. V. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13923 · Cited by 250
Self-citationA Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Transcriptomic comparison of human and mouse brain microvessels
Song, H. W., Foreman, K. L., Gastfriend, B. D., Kuo, J. S., Palecek, S. P., & Shusta, E. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-69096-7 · Cited by 155
Self-citationIn Vitro Models of the Blood–Brain Barrier
Czupalla, C. J., Liebner, S., & Devraj, K. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0320-7_34 · Cited by 171
“BBB ECs are known to dedifferentiate in vitro, and there are also treatments that help retain the native characteristics for a longer period of time [ 7 , 8 ].”
BackgroundThe in vivo endothelial cell translatome is highly heterogeneous across vascular beds
Cleuren, A. C. A., van der Ent, M. A., Jiang, H., Hunker, K. L., Yee, A., Siemieniak, D. R., Molema, G., Aird, W. C., Ganesh, S. K., & Ginsburg, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912409116 · Cited by 152
“This finding supports previous reports (11-14) demonstrating”
BackgroundMethodCannon, R. E., Peart, J. C., Hawkins, B. T., Campos, C. R., & Miller, D. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203534109 · Cited by 141
“We suspect that these differences reflect changes in cell physiology that occurred when the endothelial cells were isolated and developed into a continuous line (33).”
BackgroundLyck, R., Ruderisch, N., Moll, A. G., Steiner, O., Cohen, C. D., Engelhardt, B., Makrides, V., & Verrey, F. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.72 · Cited by 140
Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 151
Barrier mechanisms in the Drosophila blood-brain barrier
Hindle, S. J., & Bainton, R. J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00414 · Cited by 139
“Oatp33Ea shows very low expression in all cell types of the adult brain; as its expression was previously shown in the fly head, Oatp33Ea may therefore localize to the fat bodies of the head rather than the brain. As mentioned above, the organic anion transporter Oatp58Dc is expressed in the PG, SPG and post-mitotic n…”
BackgroundInfluentialModeling the blood–brain barrier using stem cell sources
Lippmann, E. S., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-2 · Cited by 122
“In addition, as has recently been performed for primary cultured BMECs [38,112] and the hCMEC/D3 line [113-115], transcriptome, proteome, and functionality tests will be required to determine how closely these cells resemble their in vivo counterparts and to determine which types of BBB studies are best supported by t…”
Self-citationWinger, R. C., Koblinski, J. E., Kanda, T., Ransohoff, R. M., & Muller, W. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400700 · Cited by 113
“Brain ECs, irrespective of their species, lose many of their BBB properties in vitro (42, 43).”
BackgroundCanfield, S. G., Stebbins, M. J., Faubion, M. G., Gastfriend, B. D., Palecek, S. P., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0145-6 · Cited by 113
Self-citationMeox2/Tcf15 Heterodimers Program the Heart Capillary Endothelium for Cardiac Fatty Acid Uptake
Coppiello, G., Collantes, M., Sirerol-Piquer, M. S., Vandenwijngaert, S., Schoors, S., Swinnen, M., Vandersmissen, I., Herijgers, P., Topal, B., van Loon, J., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013721 · Cited by 109
Cardoso, F. L., Kittel, Á., Veszelka, S., Palmela, I., Tóth, A., Brites, D., Deli, M. A., & Brito, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035919 · Cited by 110
“TEER and paracellular permeability to small molecule tracers provide information on barrier integrity in various in vitro BBB models [29,33,37].”
BackgroundAranguren, X. L., Agirre, X., Beerens, M., Coppiello, G., Uriz, M., Vandersmissen, I., Benkheil, M., Panadero, J., Aguado, N., Pascual-Montano, A., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483255 · Cited by 113
Hawkins, B. T., Sykes, D. B., & Miller, D. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5103-09.2010 · Cited by 102
“For example, mRNA for the flt-1 receptor is decreased 21-fold in primary brain endothelial cell culture compared to freshly isolated capillaries (Calabria and Shusta, 2008).”
BackgroundÁsgeirsdóttir, S. A., Solingen, C. V., Kurniati, N. F., Zwiers, P. J., Heeringa, P., van Meurs, M., Satchell, S. C., Saleem, M. A., Mathieson, P. W., Banas, B., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00400.2011 · Cited by 107
“Taking endothelial cells from an organ into a culture system leads to a major drift of genes (6) and major changes in responsiveness to, e.”
BackgroundEndothelial Cell Dysfunction and Injury in Subarachnoid Hemorrhage
Kumar, T. P., McBride, D. W., Dash, P. K., Matsumura, K., Rubí, A. F., & Blackburn, S. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1213-7 · Cited by 110
Infection of the endothelium by members of the order Rickettsiales
Walker, D. H., & Valbuena, G. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0186 · Cited by 105
In vitro modeling of blood–brain barrier and interface functions in neuroimmune communication
Erickson, M. A., Wilson, M., & Banks, W. A. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00187-3 · Cited by 104
A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells
Qi, D., Lin, H., Hu, B., & Wei, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.020 · Cited by 94
Blood–brain barrier modeling with co‐cultured neural progenitor cell‐derived astrocytes and neurons
Lippmann, E. S., Weidenfeller, C., Svendsen, C. N., & Shusta, E. V. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07434.x · Cited by 92
Self-citationLa Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies.
Stanimirovic, D., Kemmerich, K., Haqqani, A., & Farrington, G. K. (2014) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.06.005 · Cited by 59
Helms, H. C. C., Waagepetersen, H. S., Nielsen, C. U., & Brodin, B. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9237-6 · Cited by 73
“Poor transporter expression has been supported by other reports showing an incomplete transporter expression pattern in in vitro BBB models (42,43).”
ResultMolino, Y., Jabès, F., Lacassagne, E., Gaudin, N., & Khrestchatisky, M. (2014) · Journal of Visualized Experiments · doi:10.3791/51278 · Cited by 86
Wang, N., Wang, Y., Cai, B., Wang, G.-Y., Li, J., & Piao, X.-X. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.172320 · Cited by 67
“The medium was replaced every 3 days (Fischer et al., 1999; Gaillard et al., 2000; Gomez and Reich, 2003; Shen et al., 2004; Calabria and Shusta, 2008; Demarest et al., 2012; Hsieh et al., 2012; Chen et al., 2013).”
The Epithelial Membrane Protein 1 is a Novel Tight Junction Protein of the Blood—Brain Barrier
Bangsow, T., Baumann, E., Bangsow, C., Jaeger, M. H., Pelzer, B., Gruhn, P., Wolf, S., von Melchner, H., & Stanimirovic, D. B. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.19 · Cited by 64
“A recent study by Calabria and Shusta (2008) identified 25 transcripts with different abundance between isolated brain microvessels and cultured rat BMEC; among these, the BBB control genes, including glucose transporter, Pglycoprotein, and transferrin receptor, were significantly downregulated on…”
BackgroundA simple method for isolating and culturing the rat brain microvascular endothelial cells
Liu, Y., Xue, Q., Tang, Q., Hou, M., Qi, H., Chen, G., Chen, W., Zhang, J., Chen, Y., & Xu, X. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.08.004 · Cited by 59
Tian, X., Peng, J., Zhong, J., Yang, M., Pang, J., Lou, J., Li, M., An, R., Zhang, Q., Xu, L., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13833 · Cited by 55
The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier
Pardridge, W. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00398 · Cited by 50
“Gene expression was measured in freshly isolated rat brain microvessels and compared to gene expression in a primary culture of rat brain endothelial cells, and BBB-related gene expression was decreased by 1 to 3 log orders of magnitude in the primary culture of brain endothelial cells (Calabria and Shusta, 2008).”
MethodA three-dimensional neural spheroid model for capillary-like network formation
Boutin, M. E., Kramer, L., Livi, L. L., Brown, T. D., Moore, C. I., & Hoffman–Kim, D. (2017) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2017.01.014 · Cited by 52
Kompass, K. S., Agapova, O. A., Li, W., Kaufman, P. L., Rasmussen, C. A., & Hernandez, M. R. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-93 · Cited by 60
“There are substantial transcriptional differences between cells in vivo and in vitro [28-30].”
BackgroundHersom, M., Helms, H. C., Schmalz, C., Pedersen, T. Å., Buckley, S. T., & Brodin, B. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00350.2016 · Cited by 48
“However, this and other models have shown downregulation of different BBB transporter and receptor systems, for instance the solute carrier (SLC) superfamily members Glut-1 and Lat-1, and the transferrin receptor as compared with the in vivo situation (13, 32).”
BackgroundPaving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells
Lauschke, K., Frederiksen, L., & Hall, V. J. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0003 · Cited by 49
“However, BMEC lines in monoculture de-differentiate and downregulate many genes involved in cell-cell adhesion and maturation compared with primary BMECs [30–32].”
Hersom, M., Helms, H. C. C., Pretzer, N., Goldeman, C., Jensen, A. I., Severin, G. W., Nielsen, M. S., Holm, R., & Brodin, B. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.08.009 · Cited by 45
“It has previously been observed that TfR as well as other BBB transport proteins can be down-regulated in endothelial cells when grown in vitro as compared to the expression in freshly isolated brain capillaries (Calabria and Shusta, 2008; Liu et al., 2014).”
Uptake Transporters at the Blood–Brain Barrier and Their Role in Brain Drug Disposition
Parvez, M. M., Sadighi, A., Ahn, Y., Keller, S. F., & Enoru, J. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102473 · Cited by 43
“…serum-free monolayer culture conditions are more sensitive to Glut-1-like uptake transporter downregulation than the efflux transporter expression [75,76]. hCMEC/D3 cell line first developed in 2005 represents a stable, easy growing, and maintenance line, with high translational capacity similar…”
BackgroundReiterer, M., & Branco, C. M. (2019) · FEBS Journal · doi:10.1111/febs.15143 · Cited by 48
Dissecting gene expression at the blood-brain barrier
Huntley, M. A., Bien-Ly, N., Daneman, R., & Watts, R. J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00355 · Cited by 38
“METHODS OF ANALYSIS Earlier transcriptomic approaches that yielded important initial insights on brain microvascular specific expression data included suppression subtractive hybridization and serial analysis of gene expression (SAGE) (Li et al., 2001; Shusta et al., 2002; Enerson and Drewes, 2006; Calabria and Shusta…”
MethodResultInfluentialIdentification and expression profiling of blood–brain barrier membrane proteins
Agarwal, N., Lippmann, E. S., & Shusta, E. V. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06481.x · Cited by 41
Self-citationTissue Non-specific Alkaline Phosphatase (TNAP) in Vessels of the Brain
Deracinois, B., Lenfant, A., Dehouck, M., & Flahaut, C. (2015) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-7197-9_7 · Cited by 38
Hawkins, B. T., Grego, S., & Sellgren, K. L. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.025 · Cited by 39
“This specialized phenotype is only partially recapitulated in cultured brain endothelial cells (Calabria and Shusta, 2008), implying that the cellular and extracellular milieu of the brain provides important cues for the differentiation and function of the microvascular endothelium (Stewart and…”
Understanding the blood–brain barrier using gene and protein expression profiling technologies
Pottiez, G., Flahaut, C., Cecchelli, R., & Karamanos, Y. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.004 · Cited by 35
Deracinois, B., Duban‐Deweer, S., Pottiez, G., Cecchelli, R., Karamanos, Y., & Flahaut, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048428 · Cited by 34
“A genomic comparison of in vivo and in vitro brain microvascular endothelial cells (ECs) that de-differentiate in culture yielded a functionally diverse set of 10 genes, the expression of which correlated with a barrier phenotype [13].”
BackgroundThe Effects of Propofol on a Human in vitro Blood-Brain Barrier Model
Hughes, J. M., Neese, O., Bieber, D. D., Lewis, K. A., Ahmadi, L. M., Parsons, D., & Canfield, S. G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.835649 · Cited by 35
“The utilization of human primary or immortalized BBB models alleviate some of these concerns, however, suboptimal barrier phenotypes often limit the extent of their efficacy (Calabria and Shusta, 2008).”
BackgroundNielsen, S. S. E., Siupka, P., Georgian, A. R., Preston, J. E., Tóth, A. E., Yusof, S. R., Abbott, N. J., & Nielsen, M. S. (2017) · Journal of Visualized Experiments · doi:10.3791/56277 · Cited by 37
Novel insights in the dysfunction of human blood-brain barrier after glycation
Hussain, M., Bork, K., Gnanapragassam, V. S., Bennmann, D., Jacobs, K., Navarette-Santos, A., Hofmann, B., Simm, A., Danker, K., & Horstkorte, R. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.004 · Cited by 33
Kato, T., Manabe, R.-I., Igarashi, H., Kametani, F., Hirokawa, S., Sekine, Y., Fujita, N., Saito, S., Kawashima, Y., Hatano, Y., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140555 · Cited by 33
In vitro and in vivo models of BBB to evaluate brain targeting drug delivery
Sharma, B., Luhach, K., & Kulkarni, G. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00004-4 · Cited by 34
Integrative analysis of the human brain mural cell transcriptome
Gastfriend, B. D., Foreman, K. L., Katt, M. E., Palecek, S. P., & Shusta, E. V. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211013700 · Cited by 32
“These findings of brain mural cell dedifferentiation in culture complement existing knowledge of brain endothelial cell dedifferentiation.(75,76) Last, we characterized human mural cell organotypicity using our integrated brain scRNA-seq dataset and scRNA-seq datasets from human heart, liver, lung, and skeletal muscle.”
MethodSelf-citationSmith, J. R., David, L. L., Appukuttan, B., & Wilmarth, P. A. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.03.020 · Cited by 26
Identification of lamprey variable lymphocyte receptors that target the brain vasculature
Lajoie, J. M., Katt, M. E., Waters, E. A., Herrin, B. R., & Shusta, E. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-09962-8 · Cited by 26
Self-citationIdentifying blood-brain-barrier selective single-chain antibody fragments
Jones, A. R., Stutz, C. C., Zhou, Y., Marks, J. D., & Shusta, E. V. (2014) · Biotechnology Journal · doi:10.1002/biot.201300550 · Cited by 24
“in trans-endothelial electrical resistance, improvements in tight junction morphology, and molecular changes that move the model more towards the in vivo situation [6, 14].”
BackgroundSelf-citationGoldeman, C., Andersen, M. V., Al-Robai, A., Buchholtz, T., Svane, N., Ozgür, B., Holst, B., Shusta, E. V., Hall, V. J., Saaby, L., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105577 · Cited by 26
Self-citationThe proteomic landscape of in vitro cultured endothelial cells across vascular beds
Groten, S. A., Smit, E. R., van den Biggelaar, M., & Hoogendijk, A. J. (2024) · Communications Biology · doi:10.1038/s42003-024-06649-w · Cited by 23
Yan, R., van Meurs, M., Popa, E. R., Li, R., Zwiers, P. J., Zijlstra, J. G., Moser, J., & Molema, G. (2018) · Shock · doi:10.1097/shk.0000000000001126 · Cited by 22
“Isolated segments retain their molecular status dictated by their invivo microenvironment, thereby avoiding transcriptional changes as observed when culturing endothelial cells (37).”
BackgroundIn Vitro Assays for Assessing BBB Permeability
Avdeef, A., Deli, M. A., & Neuhaus, W. (2015) · Wiley eBooks · doi:10.1002/9781118788523.ch10 · Cited by 25
Chaves, C., Do, T.-M., Cegarra, C., Roudières, V., Tolou, S., Thill, G., Rocher, C., Didier, M., & Lesuisse, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100967 · Cited by 18
“, reduced levels of tight junction proteins, transporters and receptors) [75,90,91].”
BackgroundCombinatorial Approaches for the Identification of Brain Drug Delivery Targets
Stutz, C. C., Zhang, X., & Shusta, E. V. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990459 · Cited by 21
“As alluded to earlier, it has been shown that primary BBB cells and immortalized BBB cell lines have significantly different gene and protein expression profiles than those found in vivo, with a number of BBB-selective genes being downregulated [54, 55].”
BackgroundSelf-citationSzöke, K., Reinisch, A., Østrup, E., Reinholt, F. P., & Brinchmann, J. E. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.009 · Cited by 18
Madarame, H., Seuberlich, T., Abril, C. E., Zurbriggen, A., Vandevelde, M., & Oevermann, A. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01183.x · Cited by 18
Mishra, P. K., & Teale, J. M. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002099 · Cited by 15
“Previously, gene expression analysis of endothelial cells has been performed either in an in vitro setting or with whole brain endothelial cells [23,24,25,26,27], but not with endothelial cells present in specific anatomical compartments.”
BackgroundGoldeman, C., Ozgür, B., & Brodin, B. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00193-5 · Cited by 16
A human pluripotent stem cell-derived in vitro model of the blood–brain barrier in cerebral malaria
Gopinadhan, A., Hughes, J. M., Conroy, A. L., John, C. C., Canfield, S. G., & Datta, D. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00541-9 · Cited by 13
“Nevertheless, primary BMECs are subject to batch-to-batch variability [31, 32], and their barrier properties show a decline once removed from the brain’s microenvironment [33].”
BackgroundKuo, Y., Lee, C.-L., & Rajesh, R. (2018) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2018.03.003 · Cited by 13
Blood–brain barrier and neurological diseases
Takeshita, Y., & Ransohoff, R. M. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12229 · Cited by 15
“tin, laminin and proteoglycans, BMVEC act as mediators between the blood and brain.(3) They have”
BackgroundShuvaev, А. N., Kuvacheva, N. V., Morgun, A. V., Хилажева, Е. Д., & Salmina, A. B. (2016) · Современные технологии в медицине · doi:10.17691/stm2016.8.4.29 · Cited by 12
“Brain capillary endothelial cells (BCEC) play a key role in BBB properties [8].”
Multiplex expression cloning of blood–brain barrier membrane proteins
Agarwal, N., & Shusta, E. V. (2009) · PROTEOMICS · doi:10.1002/pmic.200800368 · Cited by 11
“1 TM 0 [13] CAIV Carbonic anhydrase IV NM_173897 GPI 4 [22] RACK1 Receptor for activated C-kinase BC102286 MPA 2 [4] LAMP2 Lysosomal associated membrane protein 2 BC102819 TM 9 [4] LU Lutheran blood group (Auberger B antigen included) NM_174741 TM 4 [12] SPARC Secreted protein acidic cysteine rich/osteonectin BT030548…”
Self-citationBurek, M., & Förster, C. Y. (2018) · Neuromethods · doi:10.1007/978-1-4939-8946-1_3 · Cited by 10
Maternal placenta modulates a deleterious fetal mutation†
Xu, H., Pausch, H., Venhoranta, H., Rutkowska, K., Wurmser, C., Rieblinger, B., Flisikowska, T., Frishman, D., Zwierzchowski, L., Fries, R., et al. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox064 · Cited by 9
“Samples of human and rodent placenta are however mixtures of maternal and fetal cells that cannot easily be disassociated, so comparative analysis of maternal and fetal sides is currently limited to cells cultured in vitro, which risks altering gene expression due to culture conditions and disrupted communication with…”
BackgroundTranscriptional Responses of In Vitro Blood–Brain Barrier Models to Shear Stress
Foreman, K. L., Gastfriend, B. D., Katt, M. E., Palecek, S. P., & Shusta, E. V. (2025) · Biomolecules · doi:10.3390/biom15020193 · Cited by 7
“Rat BMECs cultured in this way have been shown to express efflux transporters, as well as numerous endothelial and BBB markers [38], and rBMECs grown in companion 96-well static tissue culture wells were validated for PECAM-1 and occludin expression and localization (Figure 1B).”
InfluentialSelf-citationGomez‐Zepeda, D., Perrière, N., Glacial, F., Taghi, M., Chhuon, C., Scherrmann, J., Sergent, P., Moreau, A., Denizot, C., Parmentier, Y., et al. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116456 · Cited by 7
Drug Metabolism at the Blood–Brain and Blood–CSF Barriers
Declèves, X., Strazielle, N., Scherrmann, J., & Ghersi‐Egea, J. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_4 · Cited by 8
Guebel, D. V., Torres, N. V., & Acebes, Á. (2021) · Biology Open · doi:10.1242/bio.057950 · Cited by 6
“, 2020), but mouse and human are not completely equivalent models (Mestas and Hughes, 2004; Calabria and Shusta, 2008; Song et al., 2020; Zhang et al., 2020).”
BackgroundIn vitro methods for assessing drug access to the brain
Mangas‐Sanjuan, V., González‐Álvarez, M., González‐Álvarez, I., & Bermejo, M. (2015) · doi:10.4155/fseb2013.13.61 · Cited by 3
Hersom, M., Goldeman, C., Pretzer, N., & Brodin, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.10.001 · Cited by 4
“All of these genes were reported to be stable under the conditions used in the respective studies, and should thus have the potential of being stable in the cell culture experiments performed in the present study (Calabria and Shusta, 2008; de Jonge et al., 2007; Hersom et al., 2016; Perez et al., 2008; Thomsen et al.…”
BackgroundMethodInfluentialSato, K. (2018) · Folia Pharmacologica Japonica · doi:10.1254/fpj.152.287 · Cited by 4
Ligustrazine Alleviates Blood–Brain Barrier Damage by Downregulating Expression of miR ‐297c‐5p
Guan, S., Jiang, R., Wang, X., Chen, T., Yi, P., Li, T. X., Ma, T., & Wang, F. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70367 · Cited by 2
Khafaga, A. F., Abdullaziz, I., Abdelrahman, A., & Elshahawy, I. (2021) · Microscopy and Microanalysis · doi:10.1017/s1431927621000325 · Cited by 2
Blood‐Brain Barrier: Considerations in Drug Development and Delivery
Miller, D. S., & Hawkins, B. T. (2012) · Chemical biology · doi:10.1002/9781118435762.ch8 · Cited by 2
Blood‐Brain Barrier, Considerations in Drug Development and Delivery
Miller, D. S., & Hawkins, B. T. (2009) · Wiley eBooks · doi:10.1002/9780470048672.wecb691 · Cited by 2
Adaptive Immune Responses to Infection and Opportunities for Vaccine Development ( Rickettsiaceae )
Valbuena, G. (2014) · ASM Press eBooks · doi:10.1128/9781555817336.ch10 · Cited by 1
Drug Metabolism at the Blood-Brain and Blood-CSF Barriers
Ghersi‐Egea, J., Strazielle, N., & Declèves, X. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_6 · Cited by 1
inflammationof VCAM-1 protein expression in acute MicroRNA-126 contributes to renal microvascular
Rabelink, T. J., van Zonneveld, A. J., Satchell, S. C., Saleem, M. A., Mathieson, P. W., Banas, B., Solingen, C. V., Kurniati, N. F., Zwiers, P. J., & Heeringa, P. (2012)
Blood–Brain Barrier: Genomics, Proteomics, Disease Targets, and Drug Delivery
Duzenli, O. F., & Öner, F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803796-6.00002-2
In Vitro Models of the Blood–Brain Barrier to Better Understand the Pathophysiology of Brain Edema
Al-Ahmad, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803196-4.00005-9
Identifying New Therapeutics in Experimental Subarachnoid Hemorrhage
Tso, M. K. (2018) · TSpace (University of Toronto)
Structure and Regulation of the Blood–Brain Barrier
Kuo, Y., Lee, C., & Hsu, J. (2016) · Wiley eBooks · doi:10.1002/9781119075691.ch18
Blood–brain barrier genomics: the discovery of new targeted therapeutics
Wang, Y., & Li, J. Y. (2015) · doi:10.4155/fseb2013.13.54
Vascular development and organogenesis
Bautch, V. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822546-2.00005-8 · Cited by 1
Cegarra, C. (2022) · theses.fr (ABES) · doi:10.70675/a88ce275zc265z4d42zbd24z29c3fcb1cd8b
Traditional practices in CNS drug delivery
Singh, G., Singh, A., Bhatia, R., Singh, R., Kaur, D., & Narang, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00028-7
Gopinadhan, A., Hughes, J. M., Conroy, A. L., John, C. C., Canfield, S. G., & Datta, D. (2024) · Figshare · doi:10.6084/m9.figshare.26714833
Goldeman, C., Ozgür, B., & Brodin, B. (2020) · Figshare · doi:10.6084/m9.figshare.12177711
Metadata
- Authors
- Calabria, A. R., & Shusta, E. V.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Shusta, Eric V
- ORCID
- Shusta, Eric V
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2007-06-13
- Volume
- 28
- Issue
- 1
- Pages
- 135-148
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC2637221
- OpenAlex
- W2088955402
- Cited by
- 109
- References
- 49
- Citations by year
- 2025: 2 · 2024: 10 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 11 · 2017: 7 · 2016: 8 · 2015: 10 · 2014: 9 · 2013: 5 · 2012: 7
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA013834, R21AA013834)
- National Institute of Neurological Disorders and Stroke (R01NS052649, NS052649.)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- brain microvascular endothelial cells, blood-brain barrier, in vitro BBB model, suppression subtractive hybridization, differentially expressed genes, cortisol, gene expression profiling, angiogenesis, neurogenesis, transport genes
- MeSH terms
- Animals, Anti-Inflammatory Agents, Biological Transport, Blood-Brain Barrier, Cell Separation, Cells, Cultured, Gene Expression Regulation, Hydrocortisone, Male, Models, Biological, Protein Synthesis Inhibitors, Puromycin, Genome, Neovascularization, Physiologic, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Endothelial Cells, Rats, Cell Dedifferentiation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.